ArticleCancer management and research2025

Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma.

Jiaran Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.